Calunod, Alma .

HRN: 29-02-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CEFUROXIME 500MG (TAB)
05/21/2026
05/28/2026
ORAL
500mg
BID
S/P NSVD With Perineorrhaphy
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: